This program focuses on early symptom identification and timely diagnosis in patients with pulmonary hypertension (PH). Learn how appropriate risk stratification can facilitate the effective management of PH. Our experts also stress the importance of asking the right questions and offer strategies for achieving well-rounded communication with patients and their caregivers.
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Did you know that a timely diagnosis and risk stratification can improve outcomes and quality of life for your patients with pulmonary hypertension?
Live
Broadcast
1.00 available credits
Information
September 10, 2024
01:00 PM - 02:00 PM EDT
Virtual
Share
This live broadcast will start in exactly:
- 0
Day(s)
- 0
Hour(s)
- 0
Minute(s)
- 0
Second(s)
Share
Share
Share this program on:
Details
Presenters
Comments
Overview
Agenda
1:00 – 1:05 PM
Welcome and Introductions
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
1:05 – 1:20 PM
Case 1 – CTD PH Case
Martha Kingman, NP
1:20 – 1:35 PM
Case 2 – Heritable PH
Susanne McDevitt, DNP, ACNP-BC
1:35 – 1:50 PM
Findings From the 7th World Symposium and Their Impact on Practice
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
1:50 – 2:00 PM
Audience Q&A
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Martha Kingman, NP
Dallas, TXDr. Kingman has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Aerami, Aerovate, Gossamer, Janssen, Liquidia, MerckSusanne McDevitt, DNP, ACNP-BC
Nurse Practitioner
University of Michigan
Ann Arbor, MIDr. McDevitt has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Aerami, Gossamer, Janssen, Liquidia, Merck, United Therapeutics
Research: Aerovate, Gossamer, Janssen, MerckReviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Prerna Poojary, PhD has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Increase knowledge of pulmonary hypertension (PH) diagnostic and treatment approaches
- Recognize clinically deteriorating patients
- Recognize and manage treatment-related adverse events
- Utilize tools to appropriately complete risk stratification in patients with PH
- Demonstrate competency in communication with patients and other referral providers to reach underserved patients for confirmatory and earlier diagnosis
Target Audience
This activity has been designed to meet the educational needs of physician assistants, nurse practitioners, and nurses as well as all other healthcare providers involved in managing patients with pulmonary hypertension.
Accreditation and Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC) and the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for the healthcare team.Global Learning Collaborative (GLC) designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 contact hour/0.1 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-098-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Provider(s)/Educational Partner(s)
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME, LLC, is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.
Commercial Support
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of TotalCME, LLC, you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Details
Presenters
Comments
Recommended
Overview
This program focuses on early symptom identification and timely diagnosis in patients with pulmonary hypertension (PH). Learn how appropriate risk stratification can facilitate the effective management of PH. Our experts also stress the importance of asking the right questions and offer strategies for achieving well-rounded communication with patients and their caregivers.
Agenda
1:00 – 1:05 PM
Welcome and Introductions
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
1:05 – 1:20 PM
Case 1 – CTD PH Case
Martha Kingman, NP
1:20 – 1:35 PM
Case 2 – Heritable PH
Susanne McDevitt, DNP, ACNP-BC
1:35 – 1:50 PM
Findings From the 7th World Symposium and Their Impact on Practice
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
1:50 – 2:00 PM
Audience Q&A
Martha Kingman, NP &
Susanne McDevitt, DNP, ACNP-BC
Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Martha Kingman, NP
Dallas, TXDr. Kingman has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Aerami, Aerovate, Gossamer, Janssen, Liquidia, MerckSusanne McDevitt, DNP, ACNP-BC
Nurse Practitioner
University of Michigan
Ann Arbor, MIDr. McDevitt has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Aerami, Gossamer, Janssen, Liquidia, Merck, United Therapeutics
Research: Aerovate, Gossamer, Janssen, MerckReviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Prerna Poojary, PhD has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Increase knowledge of pulmonary hypertension (PH) diagnostic and treatment approaches
- Recognize clinically deteriorating patients
- Recognize and manage treatment-related adverse events
- Utilize tools to appropriately complete risk stratification in patients with PH
- Demonstrate competency in communication with patients and other referral providers to reach underserved patients for confirmatory and earlier diagnosis
Target Audience
This activity has been designed to meet the educational needs of physician assistants, nurse practitioners, and nurses as well as all other healthcare providers involved in managing patients with pulmonary hypertension.
Accreditation and Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC) and the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for the healthcare team.Global Learning Collaborative (GLC) designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. PAs should claim only the credit commensurate with the extent of their participation in the activity.Global Learning Collaborative (GLC) designates this activity for 1 contact hour/0.1 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-098-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Provider(s)/Educational Partner(s)
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME, LLC, is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.
Commercial Support
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of TotalCME, LLC, you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.